RxDoctor Payments Data

Richard Britton, DO

Family Medicine · Cartersville, GANPI 1043287329

Payments from drug & device makers

$4,848in general payments, 2019–2025

Across 287 payments — averaging $16.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$718
  • AstraZeneca$595
  • GSK$486
  • AbbVie$356
  • Novo Nordisk$355
  • Lilly USA, LLC$226
  • plus $2K from 33 others

What the payments were for

  • Food & beverage$4,848100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,848 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$41,782
Medicare patients
46
Services billed
685

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin122$103,936
OzempicSemaglutide91$93,935
FarxigaDapagliflozin Propanediol105$74,299
EliquisApixaban76$65,450
Trelegy ElliptaFluticasone/Umeclidin/Vilanter76$64,277
JanuviaSitagliptin Phosphate49$58,609
KevzaraSarilumab12$51,075
Spiriva HandihalerTiotropium Bromide55$38,827
TrulicityDulaglutide36$38,675
MyrbetriqMirabegron48$37,849
XareltoRivaroxaban35$30,329
LinzessLinaclotide38$29,760
Invega SustennaPaliperidone Palmitate11$26,892
ProliaDenosumab11$19,529
RybelsusSemaglutide18$17,214

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat, Combivent Respimat$217$132,783165 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Brilinta$595$115,921187 claims
Novo NordiskOzempic, Rybelsus$355$111,148109 claims
MerckJanuvia, Janumet, Dulera$118$78,37584 claims
GSKTrelegy Ellipta, Breo Ellipta$486$73,92092 claims
PfizerEliquis, Premarin$192$73,177106 claims
Johnson & JohnsonXarelto, Invega Sustenna$61$57,22146 claims
Lilly USA, LLCTrulicity$226$38,67536 claims
Astellas Pharma US IncMyrbetriq$20$37,84948 claims
AbbVieLinzess$356$29,76038 claims
AmgenProlia$718$19,52911 claims
Kowa Pharmaceuticals America, Inc.Livalo$30$6,16213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Cartersville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →